| cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors S Censini, C Lange, Z Xiang, JE Crabtree, P Ghiara, M Borodovsky, ... Proceedings of the National Academy of Sciences 93 (25), 14648-14653, 1996 | 2297 | 1996 |
| Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial “pan-genome” H Tettelin, V Masignani, MJ Cieslewicz, C Donati, D Medini, NL Ward, ... Proceedings of the National Academy of Sciences 102 (39), 13950-13955, 2005 | 1688 | 2005 |
| Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing M Pizza, V Scarlato, V Masignani, MM Giuliani, B Arico, M Comanducci, ... Science 287 (5459), 1816-1820, 2000 | 1359 | 2000 |
| Helicobacter pylori Virulence and Genetic Geography A Covacci, JL Telford, G Del Giudice, J Parsonnet, R Rappuoli Science 284 (5418), 1328-1333, 1999 | 1309 | 1999 |
| Complete genome sequence of Neisseria meningitidis serogroup B strain MC58 H Tettelin, NJ Saunders, J Heidelberg, AC Jeffries, KE Nelson, JA Eisen, ... Science 287 (5459), 1809-1815, 2000 | 1274 | 2000 |
| The microbial pan-genome D Medini, C Donati, H Tettelin, V Masignani, R Rappuoli Current opinion in genetics & development 15 (6), 589-594, 2005 | 999 | 2005 |
| Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA … Z Xiang, S Censini, PF Bayeli, JL Telford, N Figura, R Rappuoli, ... Infection and immunity 63 (1), 94-98, 1995 | 769 | 1995 |
| A universal vaccine for serogroup B meningococcus MM Giuliani, J Adu-Bobie, M Comanducci, B Aricò, S Savino, L Santini, ... Proceedings of the National Academy of Sciences 103 (29), 10834-10839, 2006 | 737 | 2006 |
| Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation M Stein, R Rappuoli, A Covacci Proceedings of the National Academy of Sciences 97 (3), 1263-1268, 2000 | 720 | 2000 |
| Development of a mouse model of Helicobacter pylori infection that mimics human disease M Marchetti, B Arico, D Burroni, N Figura, R Rappuoli, P Ghiara Science 267 (5204), 1655-1658, 1995 | 705 | 1995 |
| An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus E Traggiai, S Becker, K Subbarao, L Kolesnikova, Y Uematsu, ... Nature medicine 10 (8), 871-875, 2004 | 644 | 2004 |
| Living dangerously: how Helicobacter pylori survives in the human stomach C Montecucco, R Rappuoli Nature Reviews Molecular Cell Biology 2 (6), 457-466, 2001 | 576 | 2001 |
| Reverse vaccinology R Rappuoli Current opinion in microbiology 3 (5), 445-450, 2000 | 574 | 2000 |
| Identification of a universal Group B streptococcus vaccine by multiple genome screen D Maione, I Margarit, CD Rinaudo, V Masignani, M Mora, M Scarselli, ... Science 309 (5731), 148-150, 2005 | 559 | 2005 |
| Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients F Dotta, S Censini, AGS van Halteren, L Marselli, M Masini, S Dionisi, ... Proceedings of the National Academy of Sciences 104 (12), 5115-5120, 2007 | 533 | 2007 |
| Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae H Tettelin, V Masignani, MJ Cieslewicz, JA Eisen, S Peterson, ... Proceedings of the National Academy of Sciences 99 (19), 12391-12396, 2002 | 517 | 2002 |
| c‐Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs M Stein, F Bagnoli, R Halenbeck, R Rappuoli, WJ Fantl, A Covacci Molecular microbiology 43 (4), 971-980, 2002 | 506 | 2002 |
| A pneumococcal pilus influences virulence and host inflammatory responses MA Barocchi, J Ries, X Zogaj, C Hemsley, B Albiger, A Kanth, S Dahlberg, ... Proceedings of the National Academy of Sciences 103 (8), 2857-2862, 2006 | 497 | 2006 |
| Reverse vaccinology, a genome-based approach to vaccine development R Rappuoli Vaccine 19 (17-19), 2688-2691, 2001 | 479 | 2001 |
| Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870 V Masignani, M Comanducci, MM Giuliani, S Bambini, J Adu-Bobie, ... The Journal of experimental medicine 197 (6), 789-799, 2003 | 472 | 2003 |
Mariagrazia PizzaGSK VaccinesEmail verificata su gsk.com
